Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Diabetes and obesity are considered risk factors, in addition to heart disease, high blood pressure, and other conditions affecting hormone balance, such as hyperthyroidism
(US) Neuraly Inc
The FDA evaluates safety, efficacy, and quality through the New Drug Application (NDA) process before approval and requires ongoing post-market safety monitoring
Its extended 2030 hour half-life means once-daily subcutaneous injections maintain stable elevated serum IGF-1 throughout the 24-hour cycle
US$ 21.94
US$ 27.37
US$ 22.07
US$ 22.93
US$ 26.11
